Tuberculosis (TB) is the most frequent cause of death from a single infectious agent. While active disease results from about 5% of exposures, most develop a 'latent' infection without symptoms. Most cases of recurrent TB result from 'reactivation' of such infections, although exogenous re-infection is a significant factor in endemic regions, calling into question the efficacy of 'naturally-acquired' immunity. Live Mycobacterium bovis bacillus Calmette-Guerin (BCG) is the only vaccine currently available. While protective in children, it has had negligible impact on the global Tb epidemic and is unsafe in immunodeficient individuals. We have recently shown that consecutive immunization with DNA vaccines and attenuated fowlpoxvirus (FPV) vectors encoding similar model vaccine antigens generates high levels of antigen-specific, interferon-gamma-secreting CD4+ and CD8+ T cells that persist in vivo for at least 6 months and, importantly, exhibit markedly increased sensitivity for the immunizing antigen. In terms of T cell memory, antigen challenge leads to rapid expansion of systemic and mucosal T cell effectors in DNA/FPV prime-boosted animals, reaching levels as high as 30% of total T cell numbers. The latter may be particularly important in pulmonary TB, where little attention has been paid to local immune responses. The primary aim of this proposal is test the hypothesis that prime-boost vaccination-induced T cell responses will control primary infection and reactivation of latent TB infection. Our goal is to generate protective T cell responses in both systemic and mucosal (pulmonary) tissues against key mycobacterial antigens expressed in acute and latent stages of infection. Specifically, we will determine protective efficacy of systemic (IM) prime-boosting against (i) acute infection following low-close aerosol challenge of vaccinated mice with M. tuberculosis and (ii) reactivation in a murine model of latent TB disease. We will also (iii) study the protective capacity of our prime-boost vaccines when given mucosally (IN) and will characterize systemic and mucosal (pulmonary) CD4+ and CD8+ T cell responses in each of these models. Codon optimization of mycobacterial genes expressed in our vaccines and co-delivery of IL-15 genes will be used in attempts to further enhance the magnitude and memory of T cell responses. The capacity of this approach to generate strong, sustained Th1-type CD4+ and CD8+ T cell responses is particularly attractive in the context of TB and HIV infection, where maintenance of Th1 responses is critical for protective immunity.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL076100-05
Application #
7568962
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
5
Fiscal Year
2008
Total Cost
$388,050
Indirect Cost
Name
Louisiana State Univ Hsc New Orleans
Department
Type
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Samuelson, Derrick R; Burnham, Ellen L; Maffei, Vincent J et al. (2018) The respiratory tract microbial biogeography in alcohol use disorder. Am J Physiol Lung Cell Mol Physiol 314:L107-L117
Maffei, Vincent J; Kim, Sangkyu; Blanchard 4th, Eugene et al. (2017) Biological Aging and the Human Gut Microbiota. J Gerontol A Biol Sci Med Sci 72:1474-1482
Byerley, Lauri O; Samuelson, Derrick; Blanchard 4th, Eugene et al. (2017) Changes in the gut microbial communities following addition of walnuts to the diet. J Nutr Biochem 48:94-102
Samuelson, Derrick R; Shellito, Judd E; Maffei, Vincent J et al. (2017) Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLoS Pathog 13:e1006426
Goldsmith, Felicia; Guice, Justin; Page, Ryan et al. (2017) Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fat. Mol Nutr Food Res 61:
Ruan, Sanbao; Cai, Yang; Ramsay, Alistair J et al. (2017) B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection. Vaccine 35:672-679
Naftolin, Frederick; Mehr, Holly; Fadiel, Ahmed (2016) Sex Steroids Block the Initiation of Atherosclerosis. Reprod Sci 23:1620-1625
Jolley, Sarah E; Alkhafaf, Qasim; Hough, Catherine et al. (2016) Presence of an Alcohol Use Disorder is Associated with Greater Pneumonia Severity in Hospitalized HIV-Infected Patients. Lung 194:755-62
Ruan, S; Samuelson, D R; Assouline, B et al. (2016) Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun 84:108-19
Lammi, Matthew R; Ghonim, Mohamed A; Pyakurel, Kusma et al. (2016) Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD. Am J Physiol Lung Cell Mol Physiol 310:L630-8

Showing the most recent 10 out of 49 publications